Oral desmopressin for treatment of adults with overactive bladder syndrome
Completed
- Conditions
- Overactive bladder syndrome (OAB)Urological and Genital DiseasesBladder disorders
- Registration Number
- ISRCTN61712514
- Lead Sponsor
- Bristol Urological Institute (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Male and female patients 18 years of age or older with overactive bladder syndrome if they have an average of four or more voids in the first eight hours of the day (excluding the first void in the morning) and/or more than one incontinence episode in the first eight hours of the day during the seven days screening period.
Exclusion Criteria
1. Consistent residual volume >150 ml
2. Abnormal levels of serum/plasma sodium
3. Newly started Benign Prostatic Hypertrophy (BPH) medical/surgical treatment
4. Diabetes insipidus/primary polydipsia
5. Multiple sclerosis
6. Stress urinary incontinence
7. Pelvic organ prolapse
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method